As1411-modified liposomes to enhance drug utilization and augment the anti-tumor efficacy

Danhuan Zhang,Lingyun Chen,Yang Zhao,Hao Ni,Qiuying Quan,Jun Ma,Lingchuan Guo
DOI: https://doi.org/10.1186/s12645-024-00262-6
2024-05-16
Cancer Nanotechnology
Abstract:The utilization of liposomes in drug delivery has garnered significant attention due to their efficient drug loading capacity and excellent biocompatibility, rendering them a promising platform for tumor therapy. However, the average size of liposomes ~ 100 nm leads to liposomes being susceptible to hepatic and renal metabolism to excretion outside the body leading to poor drug delivery efficiency with a total utilization rate of less than 0.7%, resulting in unfavorable treatment outcomes.
nanoscience & nanotechnology,oncology
What problem does this paper attempt to address?